Skip NavigationSkip to Content

Synthesis of a Cosalane Analog With an Extended Polyanionic Pharmacophore Conferring Enhanced Potency As an Anti-Hiv Agent

  1. Author:
    Cushman, M.
    Insaf, S.
    Ruell, J. A.
    Schaeffer, C. A.
    Rice, W. G.
    1. Year: 1998
  1. Journal: Bioorganic & Medicinal Chemistry Letters
    1. 8
    2. 7
    3. Pages: 833-836
  2. Type of Article: Article
  1. Abstract:

    A novel cosalane analog having an extended polyanionic pharmacophore was synthesized in order to target specific cationic residues on the surface of CD4. The design rationale is based on a hypothetical binding model of cosalane to the surface of the protein. The new analog displayed an EC50 of 0.55 mu M as an inhibitor of the cytopathic effect of HIV-1(RF) in CEM-SS cells, which represents a significant increase in potency over cosalane itself (EC50 5.1 mu M) Both cosalane and the new analog are inhibitors of viral entry into target cells. (C) 1998 Elsevier Science Ltd. All rights reserved. [References: 15]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel